Search:  
 
Home About us Principal investigators Tools & Publications Links Meetings Fellowships Contact us Français









Home

***APOGEE-Net/CanGeneTest & EuroGentest Ancillary Meeting at the International Congress of Human Genetics in Montreal October 13 2011***
At the 12th International Congress of Human Genetics held in Montreal in October 2011, EuroGentest and APOGEE-Net/CanGeneTest jointly organized a session entitled "Challenges in the Translation of Genomic Innovations into Clinical Care". The session was opened by François Rousseau (Université Laval) who presented the APOGEE-Net/CanGeneTest Network and its role in addressing the challenges of translating genomic and genetic innovations into the health care system. Gert Matthijs (University of Leuven) presented the EuroGentest Network and its role in the improvement and standardization of quality in genetic testing. Joris Vermeesch (University of Leuven) described two pilot studies of external quality assessment of constitutional molecular karyotyping, and Helena Kääriäinen (University of Helsinki) described the impact of the increasing importance of genetic testing in health care. Daniel Reinharz (Université Laval) presented cost/effectiveness and cost/utility simulations for selected genetic and genomic health innovations, and Renaldo Battista (Université de Montréal) discussed the role of health technology assessment in the translational process. The session was a success as it attracted over 60 participants despite the concurrent presentation of several other events, underlining the importance of these questions to the medical and scientific community. One of the conclusions of this event was that there is strong complementarity between the activities of each Network and that there is room for even more synergy between the different teams working in this area. More information on the session can be obtained by following this link : http://www.eurogentest.org/web/info/public/ICHG_AncillaryEvent2011.xhtml=


APOGEE-Net/CanGeneTest is an international research and knowledge network studying health care and health policy challenges in genetic services, including genetic laboratory services. Its general objective is to streamline the technology transfer of clinically useful and cost/effective genetic innovations towards the health care system and support the development of evidence-informed health policies.Through a multidisciplinary approach, we aim to study the path that links the fundamental research discoveries in genetics to the use of molecular diagnostic tests in the clinical setting. Moreover, with our e-Newsletter and this WEB site, we expect to contribute to disseminate timely and relevant scientific materials to colleagues interested in this broad field of research, downstream of the gene discovery, necessary to translate the clinically valid and useful discoveries into novel health care services.

Subscribe to the Newsletter here.

CanGeneTest Newsletter Highlights :

apr 30 2013
Baby’s First Test
While all states require newborn screening for every infant, the number of conditions on a state's screening panel varies from state to state. A complete list of the conditions screened for each state can be found here.
 
apr 30 2013
New Approaches to Molecular Diagnosis
The purpose of this article is to assist physicians in recognizing where new approaches to genetic and genomic testing may be applied clinically and in being aware of the principles of interpretation of test results.
 
apr 30 2013
Chromosome Disorder Outreach
The aim if this organization is to provide support to parents of children born with rare chromosome disorders, gather together and share information, and to promote research and a positive community understanding of these disorders. The sites includes an extensive library of available up-to-date articles, detailed registry, newsletters, research opportunities.
 
apr 30 2013
9th European Cytogenetics Conference
This event will take place in Dublin, Ireland from June 29 to July the 2nd 2013. This year’s meeting celebrates 100 years of linear order of genes on chromosomes and they have specially dedicated a session to this topic. There is a session on each of the current hot topics such as Next Generation Sequencing, Chromothripsis and Copy Number Variation in clinical genetics. There is of course also room for the classical sessions on Clinical Cytogenetics, Cancer Cytogenetics, Prenatal diagnosis.
 
apr 30 2013
Description and pilot results from a novel method for evaluating return of incidental findings from next-generation sequencing technologies
The aim of this study was to develop, operationalize, and pilot test a transparent, reproducible, and evidence-informed method to determine when to report incidental findings from next-generation sequencing technologies. Using evidence-based principles, the authors proposed a threestage process